Page 18 - Astrazeneca

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

India Coronavirus Dispatch: Those already infected may still need shots

How was the nationwide dry run carried out, the next steps in the vaccine roll-out, findings from a large-scale UK study on the new variant, and more-news relevant to India's fight against Covid-19

UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient

The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against Covid-19

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Next step on vaccines

Nationwide roll-out needs meticulous planning

SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report

He said that the vaccine will be rolled out in the next 7 to 10 days

Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

Russia's sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V

India approves AstraZeneca's Covid-19 vaccine for emergency use

It is the first Covid-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States

Covishield moves closer to roll-out; SII gets in-principle nod from panel

India would need 30 million doses in the first phase when it vaccinates the essential services workers including health care professionals, municipal and police staff, etc

Top headlines: Companies hold back on capex, GST mop-up at record high

Business Standard brings you top news of the evening

AstraZeneca vaccine set to become first to get approval in India: Report

The decision would pave the way for the vaccine's rollout in the world's second-most populous country

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

Argentina authorises use of AstraZeneca vaccine against coronavirus

Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) on Wednesday approved the use of vaccine from AstraZeneca, against Covid-19 in the country

India will have coronavirus vaccine within days, says AIIMS Director

Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria said that India will have the Covid-19 vaccine within days

Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world

Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine

India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech

India drug regulator meets to discuss AstraZeneca vaccine: Report

SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people